BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
FGF21
,
T cell receptor signaling pathway
,
Ischemia
,
Liver
,
Avian flu virus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
P cadherin
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Melanoma cell line BLM overexpressing P-cadherin
Functional characterization of E- and P-cadherin in MDA-MB-231 invasive breast cancer cells
Colon cancer HCA-7 cells with CRISPR-CAS9 mediated P-cadherin (CDH3) knockout
Embryonic stem cells with E-cadherin replaced with N-cadherin
Cadherin-11 depletion in aggressive MDA-MB-231 breast cancer cells
Explore Curated Studies Results
Literature
Most Relevant Literature
Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma.
Suppression of P-cadherin expression as a key regulatory element for embryonic stem cell stemness.
PCA062, a P-cadherin Targeting Antibody-Drug Conjugate, Displays Potent Antitumor Activity Against P…
P-Cadherin Regulates Intestinal Epithelial Cell Migration and Mucosal Repair, but Is Dispensable for…
P-cadherin regulates intestinal epithelial repair, but is dispensable for colitis associated colon c…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Differential Regulation of VEGF, Cadherin, Angiopietin 2 by Trigger Oocyte Maturation With GnRHa vs …
PF-06671008 Dose Escalation Study in Advanced Solid Tumors
A Study Of PF-03732010 In Patients With Advanced Solid Tumors
Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer
Vasculopathic Injury and Plasma as Endothelial Rescue - OCTAplas Trial (EudraCT no. 2014-000452-28)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ